After A 40% Fall This Year Illumina Stock Is A Better Pick Over Its Peer

2022-10-09 12:27:40 By : Mr. Barton Zhang

UKRAINE - 2021/10/21: In this photo illustration Illumina, Inc. logo seen displayed on a smartphone ... [+] and in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

We believe that Illumina stock (NASDAQ NDAQ : ILMN), a gene sequencing company, is currently a better pick than Thermo Fisher Scientific stock (NYSE: TMO), given Illumina’s ILMN better prospects. Both companies are trading at a similar valuation of around 5x trailing revenues. If we look at stock returns, Thermo Fisher Scientific TMO , despite a fall of 18% year-to-date, has outperformed Illumina, down 43%, as well as the broader markets, with the S&P500 index falling 21%. For Illumina, legal troubles around the acquisition of Grail – a cancer blood test developer – have weighed on its stock this year. Illumina’s deal for Grail is under an antitrust review in the U.S. and Europe. There is more to the comparison, and in the sections below, we discuss why we believe ILMN stock will offer better returns than TMO stock in the next three years. We compare a slew of factors such as historical revenue growth, returns, and valuation multiple in an interactive dashboard analysis of Illumina vs. Thermo Fisher Scientific Group: Which Stock Is A Better Bet? Parts of the analysis are summarized below.

1. Thermo Fisher Scientific’s Revenue Growth Has Been Better In Recent Years

Annual Growth Forecast - ILMN vs. TMO

Thermo Fisher Scientific Is More Profitable But Comes With Higher Risk

3. The Net of It All

Stock Return Forecast - ILMN vs. TMO

While ILMN stock may outperform TMO, the Covid-19 crisis has created many pricing discontinuities, which can offer attractive trading opportunities. For example, you’ll be surprised at how counter-intuitive the stock valuation is for Abbott vs. Amerco.

What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.

ILMN & TMO Returns Compared With Trefis Multi-Strategy Portfolio

Invest with Trefis Market Beating Portfolios

See all Trefis Price Estimates